Ark Genomic Revolution Etf Profile
| ARKG Etf | USD 23.32 0.23 0.98% |
Performance0 of 100
| Odds Of DistressLess than 9
|
ARK Genomic is trading at 23.32 as of the 23rd of April 2024. This is a -0.98 percent decrease since the beginning of the trading day. The etf's lowest day price was 22.93. ARK Genomic has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for ARK Genomic Revolution are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of July 2023 and ending today, the 23rd of April 2024. Click here to learn more.
The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . More on ARK Genomic Revolution
Moving together with ARK Etf
| 0.86 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.65 | XBI | SPDR SP Biotech | PairCorr |
ARK Etf Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ARK Genomic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ARK Genomic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Ideas | (View all Themes) |
| Business Concentration | Theme ETFs, Strategy ETFs, Health, ARK ETF Trust (View all Sectors) |
| Issuer | ARK |
| Inception Date | 2014-10-31 |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 1.3 Billion |
| Average Trading Valume | 2.28 Million |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Theme |
| Market Concentration | Blended Development |
| Region | Global |
| Administrator | The Bank of NewYork Mellon Corporation |
| Advisor | ARK Investment Management LLC |
| Custodian | The Bank of NewYork Mellon Corporation |
| Distributor | Foreside Fund Services, LLC |
| Portfolio Manager | Catherine Wood |
| Transfer Agent | The Bank of NewYork Mellon Corporation |
| Fiscal Year End | 31-Jul |
| Exchange | Cboe BZX Exchange, Inc. |
| Number of Constituents | 42.0 |
| Market Maker | Jane Street |
| Total Expense | 0.75 |
| Management Fee | 0.75 |
| Country Name | USA |
| Returns Y T D | (28.92) |
| Name | ARK Genomic Revolution ETF |
| Currency Code | USD |
| Open Figi | BBG007FJPCB0 |
| 200 Day M A | 29.646 |
| 50 Day M A | 28.8137 |
| Code | ARKG |
| Updated At | 22nd of April 2024 |
| Currency Name | US Dollar |
| Type | ETF |
| In Threey Volatility | 40.35 |
| 1y Volatility | 47.95 |
ARK Genomic Revolution [ARKG] is traded in USA and was established 2014-10-31. The fund is listed under Health category and is part of ARK ETF Trust family. The entity is thematically classified as Theme ETFs. ARK Genomic Revolution presently have 2.36 B in assets under management (AUM). , while the total return for the last 3 years was -35.3%.
Check ARK Genomic Probability Of Bankruptcy
Geographic Allocation (%)
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on ARK Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding ARK Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as ARK Genomic Revolution Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top ARK Genomic Revolution Etf Constituents
| INO | Inovio Pharmaceuticals | Stock | Health Care |
| IONS | Ionis Pharmaceuticals | Stock | Health Care |
| RHHBY | Roche Holding Ltd | OTC Stock | Health Care |
| PSNL | Personalis | Stock | Health Care |
| VRTX | Vertex Pharmaceuticals | Stock | Health Care |
| EDIT | Editas Medicine | Stock | Health Care |
| TDOC | Teladoc | Stock | Health Care |
ARK Genomic Target Price Odds Analysis
In reference to a normal probability distribution, the odds of ARK Genomic jumping above the current price in 90 days from now is close to 99%. The ARK Genomic Revolution probability density function shows the probability of ARK Genomic etf to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the etf has a beta coefficient of 2.8014. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ARK Genomic will likely underperform. Additionally, aRK Genomic Revolution has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of ARK Genomic to move above the current price in 90 days from now is close to 99 (This ARK Genomic Revolution probability density function shows the probability of ARK Etf to fall within a particular range of prices over 90 days) .
ARK Genomic Top Holders
| ADOCX | Alger Dynamic Opportunities | Mutual Fund | Long-Short Equity |
| SPEDX | Alger Dynamic Opportunities | Mutual Fund | Long-Short Equity |
| TMAT | Main Thematic Innovation | Etf | Global Small/Mid Stock |
| JAVAX | James Aggressive Allocation | Mutual Fund | Allocation--70% to 85% Equity |
| DALT | Anfield Capital Diversified | Etf | Multistrategy |
ARK Genomic Revolution Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ARK Genomic market risk premium is the additional return an investor will receive from holding ARK Genomic long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ARK Genomic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ARK Genomic's alpha and beta are two of the key measurements used to evaluate ARK Genomic's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.03 | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.6 | |||
| Risk Adjusted Performance | (0.06) |
ARK Genomic Revolution Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. ARK Genomic Revolution Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ARK Genomic price patterns.
ARK Genomic Against Markets
Picking the right benchmark for ARK Genomic etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ARK Genomic etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ARK Genomic is critical whether you are bullish or bearish towards ARK Genomic Revolution at a given time. Please also check how ARK Genomic's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ARK Genomic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
How to buy ARK Etf?
Before investing in ARK Genomic, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ARK Genomic. To buy ARK Genomic etf, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ARK Genomic. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ARK Genomic etf. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located ARK Genomic Revolution etf in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased ARK Genomic Revolution etf, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the etf
It's important to note that investing in stocks, such as ARK Genomic Revolution, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in etf prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy ARK Etf please use our How to Invest in ARK Genomic guide.
Already Invested in ARK Genomic Revolution?
The danger of trading ARK Genomic Revolution is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ARK Genomic is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ARK Genomic. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ARK Genomic Revolution is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ARK Genomic Revolution is a strong investment it is important to analyze ARK Genomic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ARK Genomic's future performance. For an informed investment choice regarding ARK Etf, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARK Genomic Revolution. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.